Identification of somatostatin-14 and -28 in rat pancreatic juice by a new HPLC method.
Recently we could demonstrate that in rats with pancreatic hypertrophy, somatostatin is secreted in higher concentrations into the pancreatic juice than into the portal vein blood. For measurement of juice somatostatin and to characterize the molecular forms, we established a new reverse-phase HPLC method, which we describe herein. This HPLC method, using a linear gradient system consisting of 0.2% heptafluorbutyric acid in 10 mM sodium acetate and acetonitrile, showed a stable recovery rate of about 85%. Applying the pure juice to this gradient system, we detect somatostatin-14 to be the major form of immunoreactive somatostatin (IRSS) in the pancreatic juice of the rat (5% of total IRSS). The remaining 35% were found to be somatostatin-28. The role of somatostatin in pancreatic juice is not known. It raises the hypothesis that it possibly interacts with the influences intraluminal intestinal growth factors. This study supports the assumption for the existence of an insuloacinar portal system to regulate exocrine pancreatic functions by islet hormones.
Dept. of Medicine, University of Essen, Germany.
M
M
Rünzi
M K
MK
Müller
M
M
Schimiczek
J
J
von Schönfeld
H
H
Goebell
D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D005069:Evaluation Studies as Topic; D008297:Male; D010189:Pancreatic Juice / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D011498:Protein Precursors / Q000032:analysis; D051381:Rats; D012844:Sincalide / Q000494:pharmacology; D013004:Somatostatin / Q000032:analysis*; D053561:Somatostatin-28
D011498:Protein Precursors; D013004:Somatostatin; D053561:Somatostatin-28; D012844:Sincalide